Ligand Pharmaceuticals Incorporated (LGNDZ)

OTCMKTS · Delayed Price · Currency is USD
0.0020
-0.0018 (-47.37%)
At close: Jun 2, 2025
-42.86%
Market Cap 2.17B
Revenue (ttm) 181.49M
Net Income (ttm) -132.62M
Shares Out n/a
EPS (ttm) -7.11
PE Ratio n/a
Forward PE 18.27
Dividend n/a
Ex-Dividend Date n/a
Volume 386,799
Average Volume 236,680
Open 0.0020
Previous Close 0.0038
Day's Range 0.0020 - 0.0020
52-Week Range 0.0006 - 0.0064
Beta 0.71
RSI 46.07
Earnings Date Aug 6, 2025

About Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neurobla... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1987
Employees 68
Stock Exchange OTCMKTS
Ticker Symbol LGNDZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.